Top Swiss Stocks Recommended by Leading Analysts for Your Investment Portfolio
Revamped: Swiss Stocks Back on German Exchanges from May 2025
Get ready, investors! The Swiss stock scene is making a comeback on German exchanges starting May 2025, after a five-year absence due to a squabble between the EU and Switzerland. Now, you'll have the chance to trade Swiss stocks directly on platforms like Xetra[1][2][3].
If you're on the hunt for compelling investment prospects, here are some top Swiss picks courtesy of analysts:
- BB Biotech and Cosmo Pharmaceuticals: Two promising biotech players worth considering.
The Swiss exchange delivers a broad range of companies, with a focus on pharma, biotech, and machinery. It presents an intriguing playground for investors seeking diverse opportunities[2].
On a side note, securing access to our website's premium content may involve setting up a subscription via Piano, an external service provider. This could potentially write your usage profile, even beyond the European Economic Area. Your consent to this also covers data transfers to third countries, such as the USA, in accordance with Art 49 para. 1 lit. a) GDPR. For more details on privacy policies, please refer to our privacy policy and privacy statement, both easily accessible at the footer of our offering anytime[4][5]. You can withdraw your consent at any time via the "Withdraw tracking" link in the footer of our offering[5].
[1] https://www.boerse-frankfurt.de/xetra[2] https://www.reuters.com/world/europe/swiss-stocks-resume-trading-german-exchange-2022-02-02/[3] https://www.bloomberg.com/news/articles/2021-12-16/swiss-stock-market-poised-for-return-to-german-bourses-in-2025[4] https://www.daimler.com/life-at-daimler/privacy-statement[5] https://www.daimler.com/company/our-commitment/data-protection.html#tableOfContents
What's the status of GDPR with respect to investing in Swiss stocks offered on Xetra? To ensure access to premium content about such finance topics, agreeing to the terms under Art 49 para. 1 lit. a) GDPR might be necessary, which could potentially write your usage profile beyond the European Economic Area.
Starting May 2025, Swiss stocks will resume trading on German exchanges, providing investing opportunities in companies such as BB Biotech and Cosmo Pharmaceuticals. The Swiss stock market offers a broad range of companies, especially focused on pharma, biotech, and machinery.
If you're considering investing, be aware that securing access to the premium content might involve setting up a subscription via an external service provider like Piano. For more details on privacy policies, please refer to the privacy policy and privacy statement accessible at the footer of our offering anytime.
You can withdraw your consent at any time via the "Withdraw tracking" link in the footer of our offering.
